Following the administration of the micronized fenofibrate alone, nine subjects (37.5% of 24 subjects) experienced at least one of the eight reported adverse drug reaction (ADRs) which included five cases of increased creatinine phosphokinase (CPK) levels, one case each of decreased white blood cells (WBCs), back pain, and both leg myalgia. Here, PIK3C2A is linked to Myalgia.